4
Changes in Ownership
ALX ONCOLOGY HOLDINGS INC Filed Acc 0001415889-24-028239
Options or other derivatives
- CHIEF EXECUTIVE OFFICER acquired 200,000 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| Lettmann Jason CHIEF EXECUTIVE OFFICER | 2024-12-02 | Grant or award · Employee Stock Option (right to buy) | +200,000 | 200,000 | D | ||
Loading xslF345X05/form4-12042024_091258.xml…